Galectin Therapeutics (GALT) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89.75% |
| Dec 31, 2025 | -17.20% |
| Sep 30, 2025 | 57.41% |
| Jun 30, 2025 | 46.20% |
| Mar 31, 2025 | 68.45% |
| Sep 30, 2024 | -32.89% |
| Jun 30, 2024 | -42.48% |
| Mar 31, 2024 | -32.34% |
| Sep 30, 2023 | -28.62% |
| Jun 30, 2023 | 25.69% |
| Mar 31, 2023 | 43.68% |
| Sep 30, 2022 | 56.75% |
| Jun 30, 2022 | 23.48% |
| Mar 31, 2022 | -52.24% |
| Sep 30, 2021 | -12.42% |
| Jun 30, 2021 | 22.49% |
| Mar 31, 2021 | 52.09% |
| Dec 31, 2020 | 42.83% |
| Sep 30, 2020 | 35.32% |
| Jun 30, 2020 | 21.66% |
| Mar 31, 2020 | -521.46% |
| Dec 31, 2019 | -475.31% |
| Sep 30, 2019 | -396.62% |
| Jun 30, 2019 | -395.79% |
| Mar 31, 2019 | -74.82% |
| Dec 31, 2018 | -170.32% |
| Sep 30, 2018 | -45.67% |
| Jun 30, 2018 | -15.01% |
| Mar 31, 2018 | 70.77% |
| Dec 31, 2017 | 80.13% |
| Sep 30, 2017 | 51.46% |
| Jun 30, 2017 | 43.82% |
| Mar 31, 2017 | 33.78% |
| Dec 31, 2016 | 36.25% |
| Sep 30, 2016 | 32.75% |
| Jun 30, 2016 | 38.37% |
| Mar 31, 2016 | 29.80% |
| Dec 31, 2015 | 17.27% |
| Sep 30, 2015 | 31.67% |
| Jun 30, 2015 | 23.42% |
| Mar 31, 2015 | 19.80% |
| Dec 31, 2014 | -177.70% |
| Sep 30, 2014 | -221.16% |
| Jun 30, 2014 | -575.09% |
| Mar 31, 2014 | -421.43% |
| Dec 31, 2013 | -12.01% |
| Sep 30, 2013 | 12.15% |
| Jun 30, 2013 | 61.17% |
| Mar 31, 2013 | 44.19% |
| Dec 31, 2012 | -120.69% |
| Sep 30, 2012 | -108.27% |
| Jun 30, 2012 | -127.12% |
| Mar 31, 2012 | -80.97% |
| Dec 31, 2011 | -0.38% |
| Sep 30, 2011 | -88.70% |
| Jun 30, 2011 | -101.92% |